baber/WOPTO huggingface dataset:
Patent DK-0701428-T3 (DK)
Inventor: HOEFFKES HORST
IPC: D06P3/30
Filed: 1994-05-27
Granted: 1997-12-08
Abstract: The invention concerns agents for dyeing keratin-containing fibres, the agents containing 1,2-naphthoquinone in combination with amino acids, oligopeptides, aniline derivatives, phenol derivatives, pyridine derivatives, pyridine derivatives or benzoic acid derivatives.
Patent DK-0683956-T3 (DK)
Inventor: COOKSON CHRISTOPHER J
IPC: H04N7/26
Filed: 1994-10-13
Granted: 2003-09-01
Abstract: A system for generating a video signal in a selected one of multiple aspect ratios from play of a disk on which is recorded a motion picture in only one aspect ratio. The disk includes a code indicative of the recorded aspect ratio, and the player has a default aspect ratio setting which can be changed by the user. Typically, the recorded aspect ratio is 16:9, center cut 4:3, pan scan 4:3, and letter box aspect ratios. The player automatically generates the appropriate video signal in accordance with both its default aspect ratio setting and the disk code.
Patent DK-0679874-T3 (DK)
Inventor: STEPHAN BURKHARD DR
IPC: B06B1/06
Filed: 1995-04-12
Granted: 1998-09-23
Abstract: The sound sensor (1) has an electrically-conductive housing (2), with a piezoelectric oscillator (3) in contact with the housing base (12) on one side and in contact with a contact foil (4) on the opposite side. A pressure element (6) which presses the piezoelectric oscillator against the housing base via the contact foil, has a number of projections (13) with corresponding pressure surfaces (14), uniformly distributed across the pressure foil. Pref. the pressure element has 3 projections, providing respective point pressure surfaces contacting the contact foil, with a plate spring (7) acting as an equalisation element, ensuring the electrical contact between the contact foil and the pressure element. <IMAGE>
Patent DK-0758560-T3 (DK)
Inventor: SHIUH JEROME C
IPC: C01B33/18
Filed: 1995-09-21
Granted: 2003-06-30
Abstract: Highly purified non-calcined, calcined, and flux-calcined diatomite products are disclosed, as are methods for their preparation, which bear the distinguishing porous and intricate structure of silica unique to diatomite and which have an extraordinarily high silica (i.e., silicon dioxide, SiO2) content and low density, resulting in high silica specific volume. These products often also exhibit exceptionally low soluble metals content and/or extreme brightness and can be used in filtration processes, eg. in filtering beer. <IMAGE>
Patent DK-0697401-T3 (DK)
Inventor: LABAT YVES
IPC: C07C319/02
Filed: 1995-08-10
Granted: 1999-07-12
Abstract: An ester of a mercaptocarboxylic acid of formula HS-X-COOR (I) is prepd. by reaction of NH4SH or an alkali(ne earth) sulphydride on a halo-carboxylic acid ester of formula Y-X-COOR in an (almost) anhydrous alcoholic medium under a H2S pressure of ≥ 10 bars abs..   X = 1-4C alkylene; R = 1-18C alkyl; Y = Cl or Br.
Patent DK-0771322-T3 (DK)
Inventor: HORWITZ MARCUS A
IPC: A61K39/00
Filed: 1994-11-18
Granted: 2008-11-24
Abstract: Vaccines based on one or more combinations of majorly abundant extracellular products of pathogens and methods for their use and production are presented. The most prevalent or majorly abundant extracellular products of a target pathogen are selected irrespective of their absolute molecular immunogenicity and used as vaccines to stimulate a protective immune response in mammalian hosts against subsequent infection by the target pathogen. The majorly abundant extracellular products may be characterized and distinguished by their respective N-terminal amino acid or DNA sequences. As the vaccines may comprise different combinations of the extracellular products or encoding nucleic acids, a broad range effective immunotherapeutic compositions are provided by the present invention. In addition to other infectious agents, the vaccines so produced can be used to stimulate an effective immune response against intracellular pathogens and in particular Mycobacterium tuberculosis.
Patent DK-0785886-T3 (DK)
Inventor: COUTURE JOHN R
IPC: B63B22/00
Filed: 1995-06-06
Granted: 1999-08-30
Abstract: An expendable underwater vehicle for use in training naval forces in anti-submarine warfare in ocean waters, including shallow waters, is between about three to five feet in length and about five inches in diameter, and it includes various improvements which make successful operations in shallow ocean waters, and improved operation in all ocean waters, possible. The improvements include a one-piece nose cup which allows the expendable underwater vehicle to be air launched into shallow water, a scuttle plug which allows water to fill the expendable underwater vehicle after the vehicle is expended and drops to the bottom of the ocean, and rudders and elevators of increased surface area which improve controllability of the vehicle in the water.
Patent DK-0831884-T3 (DK)
Inventor: JOHN M WOZNEY
IPC: A61L27/24
Filed: 1996-05-21
Granted: 2003-11-03
Abstract: Methods and compositions are provided for the treatment of defects and disease involving the functional attachment of connective tissue, such as tendon or ligament, to bone. Preferred methods comprise administering a composition containing a bone morphogenetic protein and a suitable carrier. The method results in the regeneration of functional attachment between the connective tissue and bone, such that minimal fibrous or granulation tissue is formed at the interface between the regenerated bone and connective tissue. The method and composition are useful for augmenting tissue grafts in reconstructive surgery. The method and compositions result in closer apposition of bone to the connective tissue at earlier time points and increased strength of fixation at earlier time points.
Patent DK-0856003-T3 (DK)
Inventor: PIER GIOVANNI BARALDI
IPC: C07D487/14
Filed: 1996-07-02
Granted: 2001-01-22
Abstract: PCT No. PCT/EP96/02881 Sec. 371 Date Jan. 22, 1998 Sec. 102(e) Date Jan. 22, 1998 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/05138 PCT Pub. Date Feb. 13, 1997Disclosed are adenosine A2a receptor antagonists of the formula wherein A is pyrazole, imidazole or triazole ring; R is R1 and R2 are independently H, OH, halogen, alkoxy, alkyl, nitro, amino, CN, haloalkyl, haloalkoxy, carboxy or carboxamido; or the OH group together with one of R1 or R2, or R1 and R2 together, form a methylenedioxy group; and n is 0-4; said compounds are useful in the treatment of cardiovascular, central nervous system, and respiratory diseases.
Patent DK-0802188-T3 (DK)
Inventor: CONNELL RICHARD DR
IPC: C07C233/22
Filed: 1997-04-07
Granted: 2001-03-05
Abstract: 16 Phenylglycinolamide derivatives (I) are new:  16 Phenylglycinolamide derivatives of formula (I) are new:  (a) A = 2-quinolinyl; D = O; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (b) A = 2-quinolinyl; D = CH2S; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (c) A = 2-quinolinyl; D = CH2NH; R1 = (R and S) cyclopentyl; R2 = R-Gly; (d) A = 2-quinolinyl; D = CH2NH; R1 = (R and S) cyclopentyl; R2 = Bn; (e) A = 2-quinolinyl; D = CONH; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (f) A = 2-quinolinyl; D = CONH; R1 = (R and S) cyclopentyl; R2 = Bn;  (g) A = 2-quinolinyl; D = CH=CH; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (h) A = Me2NCOS; D = absent; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (i) A = 2-chlorophenyl; D = CH2S; R1 = (dia A) cyclopentyl; R2 = R-Gly;  (j) A = 2-chlorophenyl; D = CH2S; R1 = (dia B) cyclopentyl; R2 = R-Gly;  (k) A = 2-chlorophenyl; D = CH2NH; R1 = (R and S) cyclopentyl; R2 = R-Gly;  (l) A = 2-chlorophenyl; D = CH2NH; R1 = (R and S) cyclopentyl; R2 = Bn;  (m) A = 2-chlorophenyl; D = CH2(Ac); R1 = (R and S) cyclopentyl; R2 = R-Gly;  (n) A = 2-chlorophenyl; D = CH2N(Ac); R1 = (R and S) cyclopentyl; R2 = Bn; (o) A = 2-chlorophenyl; D = CONH; R1 = (R and S) cyclopentyl; R2 = absent;  (p) A = 2-nitrophenyl; D = CONH; R1 = (R and S) cyclopentyl; R2 = R-Gly.
Patent DK-0834341-T3 (DK)
Inventor: IHNE ALEXANDER
IPC: B01D17/02
Filed: 1997-08-18
Granted: 2003-09-29
Abstract: This floating unit removes a light fluid layer (29) from the surface of another, more dense fluid (28). It includes a float, with an inlet tank (14) which is circular in plan, and has a tangential inlet. In the inlet tank, light and dense fluid can flow into the outlet or sink opening (20), mixed together. In the design, a separation tank (25) is included in the float, down into which the mixture flows. In the base of the separation tank there is an external heavy fluid outlet (43). At the top, a fluid overflow (45) leads up into a light fluid tank.
Patent DK-0801201-T3 (DK)
Inventor: ERNEWEIN JACQUES
IPC: E06B3/54
Filed: 1997-03-27
Granted: 2003-03-17
Abstract: The connection between a toughened glass sheet (1) having a reamed hole and another glass sheet or metal structure comprises two parts. One part (7), which fits the hole conical surface (3), has a force perpendicular to the hole axis exerted on it. The other (14) is supported on the side (6) of the sheet opposite the reamed holed and supports the reaction force. The force is sufficient to establish on the glass sheet a system of minimum localised compression restraints at a distance from the hole edge greater than 1% of the hole maximum diameter. The metal connecting piece part fitting the reamed hole conical surface has a cone opening angle greater than that of the hole. An aluminium sleeve (23) is interposed between the connecting piece and the hole to avoid excessive local constraints.
Patent DK-0902493-T3 (DK)
Inventor: BATAWI EMAD DR
IPC: H01M8/124
Filed: 1997-09-11
Granted: 2001-02-05
Abstract: The anode (3) of an electrode/electrolyte element (1) for a high temperature fuel cell comprises a sintered powder mixture of NiO, CeO2 and optionally an A2O3 type oxide (A = Sm, Y, Gd and/or Pr), to which CoO, FeO and/or MnO is added. In an electrode/electrolyte element for a high temperature fuel cell, in which the anode comprises a powder mixture which is sintered onto a ceramic electrolyte of aluminum oxide-containing yttrium-stabilized zirconia and which contains NiO, CeO2 and optionally an A2O3 type oxide (A = Sm, Y, Gd and/or Pr), the anode mixture contains 0.5-5 mole% added CoO, FeO and/or MnO to reduce its sintering temperature. An Independent claim is also included for a fuel cell battery comprising a stack of the above elements together with planar gas and air supply elements, the individual elements being in separable contact with one another.
Patent DK-1015094-T3 (DK)
Inventor: CARLSON ROBERT A
IPC: B01D39/00
Filed: 1997-03-04
Granted: 2002-10-28
Abstract: A method of manufacture of a long radial-flow filter particularly suitable for use as an input filter in a subterranean fluid (oil, gas, water) well starts with a length of multi-perforate pipe (152), which may be an integral part of the well's production tubing. The pipe is mounted in an engine lathe (120) with the perforated length between the headstock (122) and the tailstock (124) of the lathe. With the pipe rotating, a strip of metal (steel) wool (139) is wrapped around the pipe in repeated, overlapping helical layers each aligned at an acute angle X to the pipe axis, with adjacent layers angularly displaced by 2X. The completed filter has a tubular wire mesh around the pipe, between the pipe and the innermost layer of steel wool, and a multi-perforate sheath over the outermost layer of wool. <IMAGE>
Patent DK-0928184-T3 (DK)
Inventor: KLEINBERG ISRAEL
IPC: A61K8/00
Filed: 1997-03-04
Granted: 2009-09-28
Abstract: The present invention relates to oral compositions containing anti-caries agents distributed in an oral vehicle. In particular, the present invention provides oral compositions containing calcium, arginine and a cariostatic anion distributed in an oral vehicle. A method for preparing oral compositions containing anti-caries agents is also provided by the present invention. A method of reducing dental caries is described which comprises delivering a therapeutically effective amount of an oral composition containing calcium, arginine and a cariostatic anion into the oral cavity.
Patent DK-0906267-T3 (DK)
Inventor: MERZ WALTER
IPC: C07C209/88
Filed: 1997-06-09
Granted: 2002-02-18
Abstract: PCT No. PCT/EP97/02988 Sec. 371 Date Dec. 17, 1998 Sec. 102(e) Date Dec. 17, 1998 PCT Filed Jun. 9, 1997 PCT Pub. No. WO97/49665 PCT Pub. Date Dec. 31, 1997The invention concerns a new method for producing optically active 1-phenylethylamines, wherein (a) racemic 1-phenylethylamines are reacted with (S)-(-)-N-phenylcarbamate lactic acid in the presence of an aliphatic or aromatic hydrocarbon and in the presence of a lower aliphatic alcohol, wherein the reaction components are measured so that for every mole of racemic amine, between 0.25 and 0.5 mole of (S)-(-)-N-phenylcarbamate lactic acid are present, the reaction mixture is then concentrated at a liquid-phase temperature of up to 40 DEG  C., the resulting solid product is separated, treated with diluted, aqueous alkaline lye in the presence of a hydrocarbon, and the respective (R)-amine is isolated by distillation from the organic phase, and if necessary, (b) the mother liquor remaining after the separation of the solid product is reacted in the presence of a lower aliphatic alcohol with (S)-(-)-N-phenylcarbamate lactic acid, wherein the reaction components are measured so that the molar quantity of (S)-(-)-N-phenylcarbamate lactic acid is twice as great as the quantity of (R)-amine still remaining in the mother liquor, the reaction mixture is then concentrated at a liquid-phase temperature of up to 40 DEG  C., the resulting solid product is separated and the (S)-amine is isolated by distillation from the mother liquor.
Patent DK-0909361-T3 (DK)
Inventor: KIBBLE ANTHONY WILFRED
IPC: E05B63/18
Filed: 1997-07-04
Granted: 2000-10-16
Abstract: The invention relates to a latch unit which includes a bolt, a housing for the bolt, guides for the bolt in the housing, a first spring for the bolt in the housing, the first spring urging the bolt in a forwards direction towards a holding position in which an end part of the bolt is outside the housing, and a slot arrangement for the bolt, the slot arrangement comprising a first part and a second part, the slot arrangement having an active condition in which the first part is engaged with the second part whereby to retain the bolt against movement in the said forwards direction, characterized by a second spring to hold the first and second parts in the active condition. It is a particular feature of the invention that the bolt has a holding position in which it can engage a keeper, a non-holding position in which it is disengaged from the keeper and a retained position in which it cannot engage the keeper and in which it is retained by the slot arrangement, the non-holding position being between the holding and retained positions. There is also provided a method of operating a latch unit according as herein defined.
Patent DK-0981327-T3 (DK)
Inventor: PASSMORE CLARE
IPC: A61P35/00
Filed: 1998-05-07
Granted: 2003-03-10
Abstract: This invention relates to an intravaginal shell or core drug delivery device suitable for administration to female humans or animals comprises testosterone or a testosterone precursor in a polymer matrix, surrounded by a sheath, and is capable of releasing the testosterone or testosterone precursor in a substantially zero-order pattern on a daily basis for at least three weeks. The device is intended to restore circulating testosterone levels to the normal physiol, range or to induce supratherapeutic testosterone levels.
Patent DK-0983366-T3 (DK)
Inventor: THIREOS GEORGE
IPC: C12Q1/48
Filed: 1998-05-20
Granted: 2003-07-28
Abstract: The present invention relates to nucleic acids comprising a nucleotide sequence encoding at least a portion of an enzyme which catalyzes the synthesis of chitin in arthropods, inhibitors directed to said enzyme, and a method for developing said inhibitors.
Patent DK-1024815-T3 (DK)
Inventor: DUAN YONGJUN
IPC: A61P5/00
Filed: 1998-10-27
Granted: 2003-05-19
Abstract: The invention is a method of administering therapeutic iodine for treating a disorder in a mammal. The invention comprises a step of feeding said mammal an effective amount of an oxidant for an iodine species and an iodine reductant which will cause oxidation-reduction reactions upon contact with the gastric juices present in the stomach of the mammal. This is done such that molecular iodine is generated in vivo at a ratio of molecular iodine to total iodine of above at least about 0.65. The invention also discloses a non-aqueous pharmaceutically acceptable carrier with said oxidant and reductant having the ability to cause oxidation-reduction reactions upon contact with the gastric juices present in the stomach of said mammal and in an amount sufficient to generate molecular iodine, in vivo, at a ratio of molecular iodine to total iodine of above at least about 0.65.
Patent DK-0985665-T3 (DK)
Inventor: DRAUZ KARLHEINZ PROF
IPC: C07C381/12
Filed: 1999-08-25
Granted: 2003-03-17
Abstract: 3-Amino-2-pyrrolidinone derivatives (I) and their salts are produced the cyclization of a S-substituted methionine derivative (II). The S-substituted methionine (II) are new. Production of 3-amino-2-pyrrolidinone derivatives (I) and their salts comprises the cyclization of a S-substituted methionine derivative (II): R1 = H; alkyl, alkenyl, alkoxyalkyl or acyl optionally substituted with halo or groups containing N, O, P or S; cycloalkyl optionally unsaturated, optionally substituted with alkyl, alkenyl, acyl, alkoxy, alkoxyalkyl, halo or groups containing N, O, P or S and optionally containing ring hetero atoms; aryl, aralkyl, heteroaryl or heteroaralkyl optionally ring-substituted with alkyl, alkenyl, alkynyl, acyl, alkoxy, alkoxyalkyl, halo, CN, CONH2 or groups containing N, O, P or S; or a N-bonded amino acid or peptide group; R2 = H; alkyl, alkenyl, alkynyl or alkoxyalkyl optionally substituted with halo or groups containing N, O, P or S; cycloalkyl optionally unsaturated, optionally substituted with alkyl, alkenyl, acyl, alkoxy, alkoxyalkyl, halo or groups containing N, O, P or S and/or optionally containing ring hetero atoms; aryl, aralkyl, heteroaryl or heteroaralkyl optionally ring-substituted with alkyl, alkenyl, alkynyl, acyl, alkoxy, alkoxyalkyl, halo or groups containing N, O, P or S; R3 = H; acyl; a C-bonded amino acid or peptide group; or a peptide protecting group; and Y = alkylene optionally substituted with alkyl, halo, OH or phenyl; or aralkyl optionally substituted with alkyl, halo or OH. The full definitions are given in the DEFINITIONS (Full Definitions) Field. Independent claims are also included for the following: (1) S-substituted methionine derivatives of formula (II) and their addition salts; and (2) preparation of compounds of formula (II).
Patent DK-0920865-T3 (DK)
Inventor: WOOSLEY RAYMOND L
IPC: A61K31/445
Filed: 1993-09-03
Granted: 2004-04-19
Abstract: Use of a composition comprising the compound of formula I: <CHEM> or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for use in a treatment of allergic rhinitis which does not induce any significant cardiac arrhythmia, said treatment comprising administering a therapeutically effective amount of a compound of formula I to a human patient.
Patent DK-0942243-T3 (DK)
Inventor: ARENAS ALONSO ANTONIO
IPC: F25B21/04
Filed: 1999-03-08
Granted: 2006-02-13
Abstract: The element is formed by two transparent/translucent sheets (1) in which chains of thermoelectric elements (3,4) are embedded/trapped or inserted without disturbing the transparent/translucent properties. When supplied with external energy, the elements begin transmitting heat from a hot area (source) to a cold area (sink), or vice versa.
Patent DK-1104259-T3 (DK)
Inventor: MATTCHEN TERRY M
IPC: A61B17/04
Filed: 1999-08-10
Granted: 2009-08-17
Abstract: A bone fixation apparatus and method for repairing fractured bones is provided. A first pin is located on the bone adjacent the fracture and a flexible line is led to a second pin located on the other side of the fracture. A third pin is provided spaced from the first pin on the same side of the fracture and the flexible line is extended from the second pin to the third pin. A fourth pin is provided spaced from the second pin on the same side of the fracture and the flexible line is extended from the third pin to the fourth pin. Finally, the flexible line is extended from the fourth pin back to the first pin. The flexible line may be doubled up. A similar arrangement of pins and flexible line is made diametrically on the opposite side of the bone.
Patent DK-1097233-T3 (DK)
Inventor: LIANG LI-FANG
IPC: A61K48/00
Filed: 1999-07-15
Granted: 2009-03-23
Abstract: GDF promoters (e.g., GDF-8 promoters) are described. Also described are methods of using the GDF promoters to regulate tissue-specific gene expression, and to identify compounds which regulate GDF expression.
Patent DK-1051116-T3 (DK)
Inventor: BLEYER MARK W
IPC: A61K35/38
Filed: 1999-11-24
Granted: 2009-02-02
Abstract: A medical device (40) including a collagenous biomaterial (10) for causing embolus and treating an aneurysm. The collagenous biomaterial (10) includes a small intestine submucosa (12) that is configured into various components (16) for causing a vascular occlusion or a packing aneurysm lumen.
Patent DK-1214540-T3 (DK)
Inventor: EUSEBI GILBERTO
IPC: F16K1/30
Filed: 1999-12-27
Granted: 2003-08-11
Abstract: This invention concerns a high rate discharge valve for high pressure gas cylinders provided with two separate openings, one for discharging and the other for refilling gas so that the empty cylinders can be refilled quickly and easily without disconnecting the valves from the gas discharge hose. This would indirectly make it possible to refill the cylinders on site, namely in the same room where the bank of cylinders is installed.
Patent DK-1109570-T3 (DK)
Inventor: MAGILAVY DANIEL
IPC: C07K14/705
Filed: 1999-08-31
Granted: 2006-03-06
Abstract: This invention relates to methods of using inhibitors of the CD2/LFA-3 interaction in treating conditions characterized by the presence of activated T cells in mammals, including humans. Such conditions include inflammatory bowel diseases, psoriatic arthritis, rheumatoid arthritis, and multiple sclerosis.
Patent ES-2253150-T3 (ES)
Title: Maquina para cambiar los neumaticos de ruedas de vehiculos industriales.
Inventor: GONZAGA TULLIO
IPC: B60C25/138
Filed: 2000-03-24
Granted: 2006-06-01
Abstract: Una máquina para cambiar un neumático que tiene un bastidor de soporte (2), unos medios de soporte giratorios (3) para una llanta (4) de una rueda, unos medios de fijación (31) para asegurar dicha llanta(4) de la rueda a dichos medios de soporte (3); caracterizada porque tiene una herramienta de montaje (6) asegurable a un brazo de soporte de la herramienta ajustable (7) transportado por dicho bastidor de soporte (2), unos medios de accionamiento (5) para dichos medios de soporte giratorios (3), al menos, un primero y un segundo miembros de presión (8, 9) los cuales pueden estar situados en unas posiciones diametralmente opuestas con respecto a la llanta (4) de la rueda y transportados sobre dichos medios de soporte (3) y están dispuestos para actuar en cualquier lado de un neumático (13) sobre dicha llanta (4) de la rueda y, unos medios impulsores (46, 54) para accionar, inmediatamente después de su control, a cada uno de dichos primero y segundo miembros de presión (8, 9).